华邦健康(002004) - 2018 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2018 was ¥2,697,358,960.72, representing a 33.23% increase compared to ¥2,024,574,397.93 in the same period last year[8] - Net profit attributable to shareholders decreased by 33.76% to ¥96,080,842.50 from ¥145,049,990.77 year-on-year[8] - The basic earnings per share decreased by 28.57% to ¥0.05 from ¥0.07 in the same period last year[8] - The company’s net profit after deducting non-recurring gains and losses was ¥91,958,762.43, down 35.52% from ¥142,620,610.21 in the previous year[8] - The company expects a net profit attributable to shareholders for the first half of 2018 to range between CNY 28,464.34 million and CNY 38,510.58 million, reflecting a change of -15.00% to 15.00% compared to CNY 33,487.46 million in the same period of 2017[20] Cash Flow - The net cash flow from operating activities was negative at -¥45,294,248.61, a decline of 111.17% compared to ¥405,659,959.83 in the previous year[8] - The net cash flow from operating activities for Q1 2018 was -CNY 45,294,248.61, a decrease of 111.17% from CNY 405,659,959.83 in Q1 2017[18] - The company’s cash flow from investing activities improved by 83.58%, with a net cash outflow of -CNY 236,027,536.47, primarily due to reduced financial investments compared to the previous year[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥29,324,142,547.31, a slight increase of 0.80% from ¥29,090,036,715.62 at the end of the previous year[8] - The company’s financial liabilities measured at fair value increased by 112.08% to CNY 2,299,362.00, mainly due to changes in forward exchange and interest rate swaps[17] - The company’s other current assets increased by 41.47% to CNY 1,895,152,859.07, mainly due to investments in short-term bank financial products[17] - The prepayments decreased by 43.3% to CNY 152,836,433.37, primarily due to the delivery of goods from the previous period[17] Expenses - The financial expenses for Q1 2018 increased by 95.07% to CNY 224,269,447.96, primarily due to interest expenses and exchange losses[18] - The company reported a significant increase in sales expenses, which rose by 91.19% to CNY 301,233,670.25, attributed to increased sales volume and expanded consolidation scope[18] Shareholder Information - The total number of shareholders at the end of the reporting period was 115,375[12] - The largest shareholder, Tibet Huibang Technology Co., Ltd., holds 18.21% of the shares, totaling 370,449,804 shares[12] Other Financial Information - The company reported a foreign exchange loss of ¥91,000,000 during the reporting period, impacting overall profitability[16] - The weighted average return on equity decreased to 1.01% from 1.49% year-on-year[8] - The company received a special compensation of CNY 60,025,741.00 for new factory construction, leading to a 70.18% increase in special payables[17]